BC
CL icon

Barrett & Company’s Colgate-Palmolive CL Stock Holding History

Barrett & Company’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$183K Hold
2,152
– – 0.06% 159
2025
Q4 		$170K Hold
2,152
– – 0.06% 169
2025
Q3 		$172K Hold
2,152
– – 0.06% 164
2025
Q2 		$196K Buy
2,152
+1,852
+617% +$169K 0.07% 147
2025
Q1 		$28.1K Hold
300
– – 0.01% 339
2024
Q4 		$27.3K Hold
300
– – 0.01% 344
2024
Q3 		$31.1K Hold
300
– – 0.01% 319
2024
Q2 		$29.1K Hold
300
– – 0.01% 328
2024
Q1 		$27K Hold
300
– – 0.01% 338
2023
Q4 		$23.9K Hold
300
– – 0.01% 324
2023
Q3 		$21.3K Hold
300
– – 0.01% 332
2023
Q2 		$23.1K Buy
+300
New +$23.2K 0.01% 333

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Barrett & Company's CL Position: Q1 2026 in Review

Barrett & Company held its Colgate-Palmolive (CL) position steady in Q1 2026 at 2,152 shares worth $183K. The position accounts for 0.06% of the portfolio, ranked #159.

Barrett & Company first reported a position in CL in Q2 2023 and has held it in 12 quarters since. The position peaked at $196K in Q2 2025. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Barrett & Company held 2,152 shares of Colgate-Palmolive worth $183K as of Q1 2026.
  • Barrett & Company left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.06% of Barrett & Company's portfolio in Q1 2026, its #159 holding.
  • Barrett & Company first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 12 quarters since.
  • Barrett & Company's Colgate-Palmolive position peaked at $196K in Q2 2025.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.